Showing results (21-30 of 905) with videos related to
Sort By:
Pageof 91
The Medical Clinics of North America|April 16, 2003
Aldosterone as a target in congestive heart failureSanjay Rajagopalan, Bertram PittExpert Opinion on Drug Safety|April 19, 2018
The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemiaBertram Pitt, Dahlia GarzaThe American Journal of Cardiology|May 12, 2009
A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunctionAli Ahmed, Bertram PittHeart Failure Clinics|July 28, 2009
Biomarkers of extracellular matrix turnoverFaiez Zannad, Bertram PittDrugs|March 28, 2007
Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?Apurva Motivala, Bertram PittExpert Opinion on Pharmacotherapy|May 17, 2016
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromerMurray Epstein, Bertram PittExpert Opinion on Drug Safety|March 10, 2016
The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failureBertram Pitt, Patrick RossignolCirculation|July 2, 2015
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.JACC. Heart Failure|May 8, 2025
Mineralocorticoid Receptor Antagonist Use in Hypertension to Prevent Heart FailureBertram Pitt, Anand VaidyaHypertension (Dallas, Tex. : 1979)|May 8, 2024
Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart DiseaseBertram Pitt, Javier DiezPageof 91